Clinical validation of a high-performance somatic exome sequencing assay: from target-enrichment strategy to variant calling
Abstract Clinical whole-exome sequencing (WES) has revolutionized clinical diagnostics by enabling scalable, cost-effective molecular profiling to detect somatic variants and identify novel therapeutic targets. In particular, the clinical evaluation of somatic variants relies on both high-quality se...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Portfolio
2026-04-01
|
| 叢編: | npj Genomic Medicine |
| 在線閱讀: | https://doi.org/10.1038/s41525-026-00569-w |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
